Are you Dr. Davar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Amgen - One Amgen Center Drive
Mail Stop 38-3-B
Thousand Oaks, CA 91320Phone+1 805-490-0300
Summary
- Dr. Gudarz Davar, MD is a board certified neurologist in Thousand Oaks, California. He is currently licensed to practice medicine in Massachusetts. He is a Section Head at Allergan.
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1989
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1986 - 1988
- University of MichiganResidency, Neurology, 1983 - 1986
- Dalhousie University Faculty of MedicineClass of 1982
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 379 citationsPharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.Narender R. Gavva, James J. S. Treanor, András Garami, Liang Fang, Sekhar Surapaneni
Pain. 2008-05-01 - 396 citationsCB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.Mohab M. Ibrahim, Frank Porreca, Josephine Lai, Phillip J. Albrecht, Frank L. Rice
Proceedings of the National Academy of Sciences of the United States of America. 2005-02-22 - 32 citationsUtilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in EuropeManjit Matharu, Julio Pascual, Ingela Nilsson Remahl, Andreas Straube, Arlene Lum
Cephalalgia. 2017-07-31
Press Mentions
- Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
- A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
- Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS DisordersSeptember 14th, 2021
- Join now to see all
Grant Support
- Endothelin 1 Induced Pain And Metastatic Prostate CancerNational Cancer Institute1999–2001
- NMDA Receptor And Opioid Effects In Painful NeuropathyNational Institute Of Neurological Disorders And Stroke1995
- NMDA Receptor And Opioid Effects In Painful NeuropathyNational Institute Of Neurological Disorders And Stroke1991–1994
- GABA &Glycine In Dorsal Horn: Effect Of RhizotomyNational Institute Of Neurological Disorders And Stroke1988–1990